TAp63 plays compensatory roles in p53-deficient cancer cells under genotoxic stress (Q39632214)

13 September 2017

title

TAp63 plays compensatory roles in p53-deficient cancer cells under genotoxic stress (English)

1 reference

13 September 2017

1 reference

Jeng-Yuan Yao

1

1 reference

13 September 2017

Jan-Kan Chen

2

1 reference

13 September 2017

language of work or name

English

0 references

publication date

12 November 2010

1 reference

full work available at URL

13 September 2017

https://api.elsevier.com/content/article/PII:S0006291X10020735?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

https://api.elsevier.com/content/article/PII:S0006291X10020735?httpAccept=text/plain

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

Biochemical and Biophysical Research Communications

26 August 2024

published in

1 reference

13 September 2017

volume

403

1 reference

13 September 2017

issue

3-4

1 reference

13 September 2017

page(s)

310-315

1 reference

The p53 tumour suppressor protein

13 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

Live or let die: the cell's response to p53

26 August 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

Relationship between DNA double-strand break rejoining and cell survival after exposure to ionizing radiation in human fibroblast strains with differing ATM/p53 status: implications for evaluation of clinical radiosensitivity.

26 August 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

p63 and p73 in human cancer: defining the network

26 August 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

26 August 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

p63 is a p53 homologue required for limb and epidermal morphogenesis

26 August 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours

26 August 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

p53 family update: p73 and p63 develop their own identities

26 August 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

Cloning and functional analysis of human p51, which structurally and functionally resembles p53

26 August 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

Mutational analysis of the p63/p73L/p51/p40/CUSP/KET gene in human cancer cell lines using intronic primers

26 August 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

p63: Molecular complexity in development and cancer

26 August 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray

26 August 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

p63 and p73 are required for p53-dependent apoptosis in response to DNA damage

26 August 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities

26 August 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities

26 August 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

Dominant negative p63 isoform expression in head and neck squamous cell carcinoma

26 August 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

Expression profiles of p53, p63, and p73 in benign salivary gland tumors.

26 August 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

TAp63 induces senescence and suppresses tumorigenesis in vivo

26 August 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

Four-drug combination chemotherapy in advanced lung cancer: methotrexate, doxorubicin, cyclophosphamide and CCNU.

26 August 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

Early phase pharmacokinetics of doxorubicin (adriamycin) in plasma of cancer patients during single- or multiple-drug therapy

26 August 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

Proliferation of human breast cancer cells and anti-cancer action of doxorubicin and vinblastine are independent of PKC-alpha

26 August 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

Stress via p53 pathway causes apoptosis by mitochondrial Noxa upregulation in doxorubicin-treated neuroblastoma cells

26 August 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

Phosphorylation of p53 protein in A549 human pulmonary epithelial cells exposed to asbestos fibers

26 August 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

Mutant p53 can provoke apoptosis in p53-deficient Hep3B cells with delayed kinetics relative to wild-type p53

26 August 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

The promyelocytic leukaemia protein tumour suppressor functions as a transcriptional regulator of p63.

26 August 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

p63 is the molecular switch for initiation of an epithelial stratification program

26 August 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers

26 August 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

p51A (TAp63gamma), a p53 homolog, accumulates in response to DNA damage for cell regulation

26 August 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

p53 gene family p51(p63)-encoded, secondary transactivator p51B(TAp63alpha) occurs without forming an immunoprecipitable complex with MDM2, but responds to genotoxic stress by accumulation

26 August 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

The proline-rich domain in p63 is necessary for the transcriptional and apoptosis-inducing activities of TAp63

26 August 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria

26 August 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells

26 August 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage

26 August 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

A role for p53 in base excision repair.

26 August 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in UV-irradiated human fibroblasts

26 August 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

Cancer. p53, guardian of the genome

26 August 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

Axin determines cell fate by controlling the p53 activation threshold after DNA damage

26 August 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.11.025

26 August 2024

Identifiers

1 reference

13 September 2017

1 reference